异位妊娠后的阿片类药物处方与持续性阿片类药物使用
这项队列研究利用美国雇主保险理赔数据,纳入2008年11月1日至2015年9月30日期间接受治疗的15338例异位妊娠阿片类药物初治者,其中7047例(45.9%,95%CI 45.2-46.7%)在治疗时填写了阿片类药物处方,4.1%(95%CI 3.6-4.6%)发展为持续性阿片类药物使用;手术治疗者持续性使用风险低于药物治疗者(3.7% vs 6.8%;RR 0.54,95%CI 0.38-0.77)。
要点
- 异位妊娠治疗时45.9%填写阿片类药物处方,其中4.1%发展为持续性使用。
- 手术治疗者持续性阿片使用风险低于药物治疗者(3.7% vs 6.8%;RR 0.54)。
- 治疗前一年有苯二氮䓬类、抗抑郁药使用史或疼痛障碍者持续性使用风险更高。
核心结论
- 异位妊娠后新阿片类药物使用常见,约4%的新使用者发展为持续性使用,药物治疗者发生率高于手术治疗者。
- 作者认为需要制定新的疼痛管理指南以预防异位妊娠后持续性阿片类药物使用。
研究设计与样本
- 队列研究,使用美国雇主保险理赔数据识别2008年11月1日至2015年9月30日期间的异位妊娠阿片类药物初治者,共15338例。
- 治疗分为手术、药物(使用甲氨蝶呤)和未知;新阿片处方定义为治疗前1周至治疗后1周内填写的处方。
- 持续性阿片使用定义为治疗后8至90天及91至365天两个时间段内均至少填写一次阿片处方。
主要发现
- 15338例中7047例(45.9%,95%CI 45.2-46.7%)在治疗时填写了阿片处方。
- 新阿片使用者中4.1%(95%CI 3.6-4.6%)发展为持续性阿片使用。
- 持续性使用风险手术治疗者3.7% vs 药物治疗者6.8%(RR 0.54,95%CI 0.38-0.77)。
- 治疗前一年苯二氮䓬类使用史与持续性使用相关(RR 1.99,95%CI 1.43-2.78;aRR 1.57,95%CI 1.11-2.22)。
- 治疗前一年抗抑郁药使用史(RR 1.91,95%CI 1.45-2.53;aRR 1.53,95%CI 1.08-2.18)和既往疼痛障碍(RR 1.58,95%CI 1.26-1.99;aRR 1.47,95%CI 1.16-1.85)也与持续性使用相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate outpatient opioid dispensing and the incidence of persistent opioid use after ectopic pregnancy. METHODS: This cohort study used U.S. employer-based claims data to identify opioid-naïve individuals experiencing ectopic pregnancy from November 1, 2008, to September 30, 2015. Treatment was categorized as surgical, medical (using methotrexate), or unknown. New opioid prescriptions were defined as prescriptions filled from 1 week before to 1 week after an ectopic pregnancy treatment. For those who filled a new opioid prescription, we calculated the incidence and risk factors for persistent opioid use, defined as having filled at least one opioid prescription both from 8 to 90 days after treatment and from 91 to 365 days after treatment. RESULTS: Of the 15,338 individuals in our study, 7,047 (45.9%, 95% CI 45.2-46.7%) filled an opioid prescription at the time of treatment, of whom 4.1% (95% CI 3.6-4.6%) developed persistent opioid use. The risk of persistent opioid use was lower among those who had surgical compared with medical treatment (3.7% and 6.8%, respectively; relative risk [RR] 0.54, 95% CI 0.38-0.77). Variables most strongly associated with persistent opioid use were a history of benzodiazepine use (RR 1.99; 95% CI 1.43-2.78; adjusted relative risk [aRR] 1.57, 95% CI 1.11-2.22), antidepressant use (RR 1.91, 95% CI 1.45-2.53; aRR 1.53, 95% CI 1.08-2.18), and a pre-existing pain disorder (RR 1.58, 95% CI 1.26-1.99; aRR 1.47, 95% CI 1.16-1.85) in the year before treatment. CONCLUSION: New opioid use is common after an ectopic pregnancy; approximately 4% of those with new opioid use develop persistent opioid use, with the rate higher in those treated medically. New pain-management guidelines need to be developed to prevent persistent opioid use after ectopic pregnancy.
引用
- Wall-Wieler E, Shover CL, Hah JM, et al. Opioid Prescription and Persistent Opioid Use After Ectopic Pregnancy. Obstet Gynecol. 2020. PMID: 32769649. doi:10.1097/AOG.0000000000004015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。